Yhdysvallat - englanti - NLM (National Library of Medicine)

novel laboratories, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), sodium sulfate anhydrous (unii: 36kcs0r750) (sulfate ion - unii:7is9n8kpmg) - polyethylene glycol 3350 240 g in 278.26 g - peg-3350 (240 g) and electrolytes for oral solution, usp with flavor pack is indicated for bowel cleansing prior to colonoscopy or barium enema x-ray examination. peg-3350 (240 g) and electrolytes for oral solution with flavor pack is contraindicated in patients known to be hypersensitive to any of the components. peg-3350 (240 g) and electrolytes for oral solution with flavor pack is contraindicated in patients with ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or toxic megacolon.

Yhdysvallat - englanti - NLM (National Library of Medicine)

affordable pharmaceuticals, llc - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate anhydrous (unii: 36kcs0r750) (sodium cation - unii:lyr4m0nh37, sulfate ion - unii:7is9n8kpmg), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37, bicarbonate ion - unii:hn1zra3q20), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q3 - polyethylene glycol 3350 236 g in 4 l - peg-3350 and electrolytes for oral solution is indicated for bowel cleansing prior to colonoscopy and barium enema x-ray examination in adults. peg-3350 and electrolytes for oral solution is contraindicated in the following conditions: - gastrointestinal (gi) obstruction [see warnings and precautions ( 5.6)] - bowel perforation [see warnings and precautions ( 5.6)] - toxic colitis or toxic megacolon - gastric retention - ileus - hypersensitivity to any component of peg-3350 and electrolytes for oral solution [see warnings and precautions ( 5.8)] animal reproduction studies have not been conducted with peg-3350 and electrolytes for oral solution. it is also not known whether peg-3350 and electrolytes for oral solution can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. peg-3350 and electrolytes for oral solution should be given to a pregnant woman only if clearly nee

Yhdysvallat - englanti - NLM (National Library of Medicine)

braintree laboratories, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate anhydrous (unii: 36kcs0r750) (sodium cation - unii:lyr4m0nh37, sulfate ion - unii:7is9n8kpmg), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37, bicarbonate ion - unii:hn1zra3q20), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q3 - polyethylene glycol 3350 236 g in 4 l - golytely is indicated for bowel cleansing prior to colonoscopy and barium enema x-ray examination in adults. golytely is contraindicated in the following conditions: - gastrointestinal (gi) obstruction [see warnings and precautions ( 5.6)] - bowel perforation [see warnings and precautions ( 5.6)] - toxic colitis or toxic megacolon - gastric retention - ileus - hypersensitivity to any component of golytely [see warnings and precautions ( 5.8)] animal reproduction studies have not been conducted with golytely. it is also not known whether golytely can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. golytely should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when golytely is administered to a nursing woman. safety and effectiv

Yhdysvallat - englanti - NLM (National Library of Medicine)

braintree laboratories, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37, bicarbonate ion - unii:hn1zra3q20), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698) - polyethylene glycol 3350 420 g in 4 l - nulytely is indicated for bowel cleansing prior to colonoscopy in adults and pediatric patients aged 6 months or greater. nulytely is contraindicated in the following conditions: - gastrointestinal (gi) obstruction, ileus, or gastric retention - bowel perforation - toxic colitis or toxic megacolon - known allergy or hypersensitivity to any component of nulytely [ see how supplied/storage and handling ( 16) ] pregnancy category c. animal reproduction studies have not been conducted with nulytely. it is also not known whether nulytely can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. nulytely should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when nulytely is administered to a nursing woman. safety and effectiveness of nulyte

Yhdysvallat - englanti - NLM (National Library of Medicine)

lupin pharmaceuticals,inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate anhydrous (unii: 36kcs0r750) (sodium sulfate anhydrous - unii:36kcs0r750), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - polyethylene glycol 3350 236 g in 274.31 g - gavilyte-g is indicated for bowel cleansing prior to colonoscopy and barium enema x-ray examination in adults. gavilyte-g is contraindicated in the following conditions: - gastrointestinal (gi) obstruction, ileus, or gastric retention - bowel perforation - toxic colitis or toxic megacolon - known allergy or hypersensitivity to any component of gavilyte-g [see how supplied/storage and handling (16) ] pregnancy category c. animal reproduction studies have not been conducted with gavilyte-g. it is also not known whether gavilyte-g can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. gavilyte-g should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when gavilyte-g is administered to a nursing woman. safety and effectiveness of gavilyte-g in pediatric patients have not been established. clinical studies of gavilyte-g did n

Yhdysvallat - englanti - NLM (National Library of Medicine)

martin ekwealor pharmaceuticals, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 17 g in 17 g - for the treatment of occasional constipation. this product should be used for 2 weeks or less as directed by a physician. polyethylene glycol 3350 nf is contraindicated in patients with known or suspected bowel obstruction and patients known to be allergic to polyethylene glycol.

Yhdysvallat - englanti - NLM (National Library of Medicine)

delaval - glycolic acid (unii: 0wt12sx38s) (glycolic acid - unii:0wt12sx38s) - glycolic acid 30.4 g in 1 l - sanitizing post dip barrier with 5% glycerin aids in reducing the spread of mastitis-causing organisms desinfectante post ordeno con 5% de glicerina ayuda a reducir la transmision de microorganismos que causan mastitis general instructions - delaval oceanblu® pre-post is a pre and post milking sanitizing teat dip that aids in reducing the spread of mastitis-causing organisms. - use delaval ocean blu® pre-post teat sanitizer at full strength.  do not dilute. - consult veterinarian before starting or continuing to use teat dip if cow's teats are sore or chapped. - thoroughly clean and sanitize teat dip cup before each milking. - use fresh teat dip for each milking.  dip solution should be changed if it becomes visibly dirty or if sediment is introduced.  do not pour used teat dip back into original container. - discard any teat sanitizing solution that becomes dirty or contaminated for any reason. - good dairy practices suggest the thorough cleaning and sanitizing of teats before milking to avoid contamina

Yhdysvallat - englanti - NLM (National Library of Medicine)

delaval - glycolic acid (unii: 0wt12sx38s) (glycolic acid - unii:0wt12sx38s) - glycolic acid 30.4 g in 1 l - sanitizing post dip barrier with 10% emollients aids in reducing the spread of mastitis-causing organisms desinfectante post ordeno con 10% de glicerina ayuda a reducir la transmision de microorganismos que causan mastitis general instructions - oceanblu® barrier is a highly visible, persistent barrier post-dip with extended disinfection while hydrating and softening teats. - use oceanblu® barrier at full strength.  do not dilute. - consult your veterinarian before using a teat dip on a cow with sore or chapped teats. - thoroughly clean and sanitize teat dip cup before milking. - use fresh teat dip for each milking.  dip solution should be changed if it becomes visibly dirty, or if sediment is introduced.  do not pour used teat dip back into original container. - do not use for cleaning or sanitizing equipment. - discard any teat dip that becomes contaiminated for any reason. pre-dipping - for optimal removal of organic debris and to remove any residual oceanblu® barrier film, use a delaval approved pr

Australia - englanti - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - methoxy polyethylene glycol-epoetin beta, quantity: 0.05 mg - injection, solution - excipient ingredients: sodium sulfate; monobasic sodium phosphate monohydrate; poloxamer; methionine; mannitol; water for injections - mircera is indicated for the treatment of anaemia associated with chronic kidney disease (ckd).

Australia - englanti - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - methoxy polyethylene glycol-epoetin beta, quantity: 0.03 mg - injection, solution - excipient ingredients: mannitol; sodium sulfate; poloxamer; methionine; monobasic sodium phosphate monohydrate; water for injections - mircera is indicated for the treatment of anaemia associated with chronic kidney disease (ckd).